Companies: 10,795·Total market cap: $144.5T
Trulieve Cannabis Corp.

Trulieve Cannabis Corp.

TRUL.CNCNQHealthcare● Active
$17.00
+$0.55(+3.34%)
Market Cap$2.9B
P/E Ratio
52W High$17.46
52W Low$4.45

Trulieve Cannabis Corp.(TRUL.CN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

trul.cn · 股价预测 · 6 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

SellBuy

Buy

6 位分析师

共识

评级分布

Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
合计: 6 · 买入占比: 100.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $16.88

Trulieve Cannabis Corp.(TRUL.CN)的分析师共识为 Buy,基于过去 3 个月内 6 位华尔街分析师的评级。TRUL.CN 的 12 个月平均目标价为 $0.00,相对当前价 $16.88 代表 +0.0% 的潜在上行空间。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$17.725.00%

1-day model range: $17.52–$17.93. Peak: $17.93 (+5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

79%14%7%
11Buy
2Neutral
1Sell
RSI (14)79.8Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · TRUL.CN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$14.43BUY
MA 10$13.46BUY
MA 20$12.18BUY
MA 50$11.05BUY
MA 100$10.20BUY
MA 200$0.00NEUTRAL
Current $TRUL.CN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.03BUY
EMA 10$13.87BUY
EMA 20$12.87BUY
EMA 50$11.63BUY
EMA 100$10.91BUY
EMA 200$0.00NEUTRAL
Current $TRUL.CN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2024-08-06
Maintains
BuyBuy
Needham2024-05-10
Maintains
BuyBuy
Roth MKM2024-05-10
Maintains
BuyBuy
Seaport Global2024-03-05
Maintains
BuyBuy
Needham2024-03-01
Maintains
BuyBuy
Needham2023-11-09
Maintains
BuyBuy
Wedbush2023-08-11
Maintains
OutperformOutperform
Needham2023-08-10
Maintains
BuyBuy
Needham2023-05-10
Maintains
BuyBuy
Cantor Fitzgerald2023-03-09
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Trulieve Cannabis Corp. (TRUL.CN) stock. Of the recent 39 rating actions, 1 were upgrades and 0 were downgrades. 6 analysts currently cover TRUL.CN.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

TRUL.CN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$1.2B

↓ 4.6% YoY

Revenue Next Year

$1.2B

↑ 4.9% YoY

EPS This Year

$0.11

EPS Next Year

$0.18

↑ 57.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TRUL.CN EPS of $0.11 for the current fiscal year, based on estimates from 4 analysts. The TRUL.CN revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

TRUL.CN 股价预测由两类独立数据源支撑:来自 6 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。TRUL.CN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

TRUL.CN 的短期预测(明日)为 $17.72(+5.00%)。

Trulieve Cannabis Corp. 在 CNQ 上市,代码 TRUL.CN。TRUL.CN 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

TRUL.CN 预测 · 8 个问题

根据 6 位华尔街分析师,TRUL.CN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $16.88,隐含约 +0.0% 的上行空间。

TRUL.CN 目标价TRUL.CN 分析师目标价TRUL.CN 12个月目标价目标价 TRUL.CN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.